Literature DB >> 8853234

Validity of self-reported drug use in high risk populations: a meta-analytical review.

S Magura1, S Y Kang.   

Abstract

Research involving drug users and treatment evaluations continue to rely extensively on self-reports of drug use. This paper presents a meta-analytical review of 24 studies published since 1985 that examined the validity of drug self-reports in high risk populations. Only studies employing a biological criterion of validity (e.g., urinalysis, hair analysis) are included. Coefficients of chance-corrected agreement between self-reports and the validity criteria are calculated from published data to facilitate cross-study comparisons. The median conditional kappa (kappa c) was .42, considerably below the level of kappa c = .80 that represents acceptable reporting accuracy. The magnitude of drug use underreporting documented in this review could seriously bias prevalence estimates and treatment outcome studies.

Mesh:

Year:  1996        PMID: 8853234     DOI: 10.3109/10826089609063969

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  63 in total

1.  Computer-based brief motivational intervention for perinatal drug use.

Authors:  Steven J Ondersma; Sara K Chase; Dace S Svikis; Charles R Schuster
Journal:  J Subst Abuse Treat       Date:  2005-06

Review 2.  Current issues in endoscope reprocessing and infection control during gastrointestinal endoscopy.

Authors:  Douglas B Nelson; Lawrence F Muscarella
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

Review 3.  The potential for accurately measuring behavioral and economic dimensions of consumption, prices, and markets for illegal drugs.

Authors:  Bruce D Johnson; Andrew Golub
Journal:  Drug Alcohol Depend       Date:  2006-09-15       Impact factor: 4.492

4.  Interventions and Patterns of Risk in Adolescent HIV/AIDS Prevention.

Authors:  Robert M Malow; Rhonda Rosenberg; Geri Donenberg; Jessy G Dévieux
Journal:  Am J Infect Dis       Date:  2006

5.  The Variation in Arrestees' Disclosure of Recent Drug Use Across Locations, Drugs, and Demographic Characteristics.

Authors:  Andrew Golub; Hilary James Liberty; Bruce D Johnson
Journal:  J Drug Issues       Date:  2005

6.  Familias Unidas: the efficacy of an intervention to promote parental investment in Hispanic immigrant families.

Authors:  Hilda Pantin; J Douglas Coatsworth; Daniel J Feaster; Frederick L Newman; Ervin Briones; Guillermo Prado; Seth J Schwartz; José Szapocznik
Journal:  Prev Sci       Date:  2003-09

7.  Measurement of Current Substance Use in a Cohort of HIV-Infected Persons in Continuity HIV Care, 2007-2015.

Authors:  Catherine R Lesko; Alexander P Keil; Richard D Moore; Geetanjali Chander; Anthony T Fojo; Bryan Lau
Journal:  Am J Epidemiol       Date:  2018-09-01       Impact factor: 4.897

8.  Hair drug testing results and self-reported drug use among primary care patients with moderate-risk illicit drug use.

Authors:  Jan Gryczynski; Robert P Schwartz; Shannon Gwin Mitchell; Kevin E O'Grady; Steven J Ondersma
Journal:  Drug Alcohol Depend       Date:  2014-05-17       Impact factor: 4.492

9.  What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?

Authors:  Brian D Kiluk; Garrett M Fitzmaurice; Eric C Strain; Roger D Weiss
Journal:  Addiction       Date:  2018-06-27       Impact factor: 6.526

Review 10.  Measures of outcome for stimulant trials: ACTTION recommendations and research agenda.

Authors:  Brian D Kiluk; Kathleen M Carroll; Amy Duhig; Daniel E Falk; Kyle Kampman; Shengan Lai; Raye Z Litten; David J McCann; Ivan D Montoya; Kenzie L Preston; Phil Skolnick; Constance Weisner; George Woody; Redonna Chandler; Michael J Detke; Kelly Dunn; Robert H Dworkin; Joanne Fertig; Jennifer Gewandter; F Gerard Moeller; Tatiana Ramey; Megan Ryan; Kenneth Silverman; Eric C Strain
Journal:  Drug Alcohol Depend       Date:  2015-11-21       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.